BMO Capital Downgrades Marchex To Market Perform

Analysts at BMO Capital downgraded Marchex MCHX from Outperform to Market Perform. The target price for Marchex has been lowered from $14 to $5. Marchex shares have declined 44.85% over the past 52 weeks, while the S&P 500 index has surged 17.63% in the same period. Marchex's shares dipped 45.73% to closed at $4.07 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsBMO CapitalInformation TechnologyInternet Software & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!